Altamira Therapeutics Ltd. Profit Loss
Altamira Therapeutics Ltd. (CYTOF) reported Profit Loss of -$1.54 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Income Statement
ifrs-full:ProfitLoss · last filed 2025-08-29
CHF
| Period end | Profit Loss 6 month | Profit Loss 6 month as first filed | Profit Loss 12 month | Profit Loss 12 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | 3.87M CHF 20-F/A · filed 2024-04-22 | |||
| 2023-06-30 | 5.42M CHF 6-K · filed 2023-09-12 | |||
| 2022-12-31 | 26.53M CHF 20-F/A · filed 2024-04-22 | |||
| 2022-06-30 | 8.24M CHF 6-K · filed 2023-09-12 | 7.31M CHF 6-K · filed 2022-11-30 | ||
| 2021-12-31 | 17.06M CHF 20-F/A · filed 2024-04-22 | 17.39M CHF 20-F · filed 2022-04-12 | ||
| 2021-06-30 | 6.75M CHF 6-K/A · filed 2023-08-21 | |||
| 2020-12-31 | 8.20M CHF 20-F · filed 2023-05-16 | |||
| 2020-06-30 | 2.66M CHF 6-K · filed 2021-09-08 | |||
| 2019-12-31 | 6.63M CHF 20-F · filed 2022-04-12 | -6.63M CHF 20-F · filed 2020-04-16 | ||
| 2018-12-31 | 11.50M CHF 20-F · filed 2021-03-31 | -11.50M CHF 20-F · filed 2019-03-14 | ||
| 2017-12-31 | -24.41M CHF 20-F · filed 2020-04-16 | |||
| 2016-12-31 | -30.66M CHF 20-F · filed 2019-03-14 | |||
| 2015-12-31 | -29.71M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Profit Loss 6 month | Profit Loss 6 month as first filed | Profit Loss 12 month |
|---|---|---|---|
| 2025-06-30 | -$1.54M 6-K · filed 2025-08-29 | ||
| 2024-12-31 | -$8.46M 20-F · filed 2025-04-30 | ||
| 2024-06-30 | -$4.34M 6-K · filed 2025-08-29 | $4.34M 6-K · filed 2024-09-24 | |
| 2023-12-31 | -$4.31M 20-F · filed 2025-04-30 | ||
| 2023-06-30 | $5.94M 6-K · filed 2024-09-24 | ||
| 2022-12-31 | -$27.78M 20-F · filed 2025-04-30 |